-
Capivasertib Extends Progression-Free Survival in Hormone Receptor-Positive Breast Cancer
The new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
by Eric Fitzsimmons
-
Pregnancy After a Breast Cancer Diagnosis
Study finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.
by Thomas Celona
-
Disparities in Breast Cancer Outcomes for Black Women Despite Similar Recurrence Scores
Black breast cancer patients had worse outcomes in a recent study, even when cancer features aligned with white patients.
by Eric Fitzsimmons
Cancer Talk
Is Chemo-free Treatment Coming for HER2-positive Breast Cancer?
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
Germline Genetic Testing Lags Behind GuidelinesLow rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
Progress in Lung CancerNovember is Lung Cancer Awareness Month. Here are stories describing lung cancer treatment advances and the experiences of people who have been through a diagnosis.
Against All OddsAt age 26, Manny Garcia was diagnosed with and fought pancreatic cancer.
by Karon Warren